2007
DOI: 10.1016/j.thromres.2007.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Detection of shortened activated partial thromboplastin times: An evaluation of different commercial reagents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
27
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(30 citation statements)
references
References 21 publications
1
27
0
1
Order By: Relevance
“…In previous studies, several procoagulant markers have been found to be elevated in individuals with short APTTs [2][3][4][5][6][7][8][9][10], but these may not fully explain the thrombotic risk in these individuals, and thus, the presence of additional markers or risk factors can be hypothesized. In the current study, we prospectively assessed the profile of 113-test samples that yielded short APTTs in comparison with a similar number of age and sex-matched samples yielding normal APTTs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In previous studies, several procoagulant markers have been found to be elevated in individuals with short APTTs [2][3][4][5][6][7][8][9][10], but these may not fully explain the thrombotic risk in these individuals, and thus, the presence of additional markers or risk factors can be hypothesized. In the current study, we prospectively assessed the profile of 113-test samples that yielded short APTTs in comparison with a similar number of age and sex-matched samples yielding normal APTTs.…”
Section: Discussionmentioning
confidence: 99%
“…Short APTTs have traditionally been considered an artefact of problematic blood collections giving rise to in-vitro activation events; however, recent evidence suggests that short APTTs might instead reflect in-vivo events that might be associated with hypercoagulability. Thus, patients with short APTTs have increased thrombin generation, elevated FVIII and thrombin-antithrombin complex, and are at increased risk for thromboembolism, mainly venous thromboses [1][2][3][4][5][6]. Furthermore, hypercoagulability detected by a shortened APTT appears to be significantly associated with the risk of venous thromboembolism independently of other variables such as blood group and the presence of inherited thrombophilia (reviewed in [1]).…”
Section: Introductionmentioning
confidence: 99%
“…Hypercoagulability due to high levels of coagulation factors such as FVIII, FIX, FXI and fibrinogen represents increasing recognized risk factors for venous thromboembolism [5], and these factors are cumulatively assessed by the APTT. FVIII contributes to platelet aggregation and fibrin formation via thrombin generation under low shear conditions [6] and has previously been shown to be elevated in samples yielding short APTTs [7]. Our group also recently reported on variously elevated procoagulant factors (factor V, FVIII and FXI) in such samples [8].…”
Section: Introductionmentioning
confidence: 59%
“…Variation in reagents, coagulometers, and operators but also in the nature of the mode of assay operation, i.e. clot-based assays, all contribute to the lack of consistency between assay results [20,21].…”
Section: Discussionmentioning
confidence: 99%
“…Despite this standardization, poor agreement among PT methods has been observed [22]. Variability in APTT reagent sensitivity for monitoring heparin has also been observed, resulting in a lack of correlation between assays for the same samples [20,21].…”
Section: Discussionmentioning
confidence: 99%